ABCA2 and ovarian carcinoma: ABCA2 deficiency inhibits prostate tumour metastasis in vivo, potentially through reduction of the intracellular sphingolipid level96, whilst ABCA2 expression is increased in ovarian carcinoma metastases relative to primary tumours97.